Effects of androgens and estrogens and catechol and methoxy-estrogen derivatives on mitogen-activated protein kinase (ERK1,2) activity in SW-13 human adrenal carcinoma cells

Hormone and Metabolic Research

Volumn 33, Issue 3, 2001, Pages 127-130

  Brown, J W ^a,b   Kesler, C T ^a   Neary, J T ^a,b   Fishman, L M ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenal Carcinoma; ERK; MAPK; Steroids

Indexed keywords

ALDOSTERONE; ANDROGEN; CATECHOL; ESTRADIOL; ESTROGEN; ESTROGEN DERIVATIVE; HYDROCORTISONE; METHOXYESTROGEN DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; PRASTERONE; PROGESTERONE; PROTEIN SERINE THREONINE KINASE; TESTOSTERONE; UNCLASSIFIED DRUG;

ADRENAL CORTEX CARCINOMA; ARTICLE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADRENAL GLAND NEOPLASMS; ANDROGENS; ENZYME ACTIVATION; ESTROGENS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; TUMOR CELLS, CULTURED;

EID: 0035015099     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-14937     Document Type: Article

References (26)

1. 1 Shan JD, Porvari K, Ruokonen M, Karhu A, Launonen V, Hedberg P, Oikarinen J, Vihko P. Steroid-involved transcriptional regulation of human genes encoding prostatic acid phosphatase, prostate-specific antigen, and prostate-specific glandular kallikrein. Endocrinology 1997; 138: 3764-3770
2. 2 Myers RB, Oelschlager D, Manne U, Coan PN, Weiss H, Grizzle WE. Androgenic regulation of growth factor and growth factor receptor expression in the CWR22 model of prostatic adenocarcinoma. Int J Cancer 1999; 82: 424-429
3. 3 Bondy PK. Disorders of the adrenal cortex. In: Williams Textbook of Endocrinology, JD Wilson and DW Foster (eds.). Philadelphia, PA WB Saunders Company 1985: 816-890
4. 4 Gittes RF. Carcinoma of the prostate. New Engl J Med 1991; 324: 236-245
5. 5 Stearn ME, McGarvey T. Prostate cancer, therapeutics, diagnostic and basic studies. Lab Invest 1992; 67: 540-552
6. 6 Boring CC, Squires TS, Tong T. Cancer statistics. CA Cancer J Clin 1993; 43: 7-26
7. 7 Craft N, Sawyers CL. Mechanistic concepts in androgen-dependence of prostate cancer. Cancer & Metastasis Rev 1999; 17: 421-427
8. 8 Seger R, Krebs EG. The MAPK signaling cascade. FASEB J 1995; 9: 726-735
9. 9 Neary JT. MAPK cascades in cell growth and death. News in Physiol Sci 1997; 12: 286-293
10. 10 Neary JT, Rang Y, Bu Y, Yu E, Akong K, Peters CM. Mitogenic signaling by ATP P2Y purinergic receptors in astrocytes: involvement of a calcium-independent protein kinase C, extracellular signal regulated protein kinase pathway distinct from the phosphatidylinositol-specific phospholipase C, calcium pathway. J Neurosci 1999; 19: 4211-4220
11. 11 Kyriakis JM, Avruch J. Sounding the Alarm: Protein kinase cascades activated by stress and inflamation. J Biol Chem 1996; 271: 24313-24316
12. 12 Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME. Cell survival promoted by the Ras-MAPK signalling pathway by transcription-dependent and independent mechanisms. Science 1999; 286: 1358-1362
13. 13 Bhatt RR, Ferrell JE Jr. The protein kinase p90 Rsk as an essential mediator of cytostatic factor activity. Science 1999; 286: 1362-1365
14. 14 Gross SD, Schwab MS, Lewellyn AL, Maller JL. Induction of metaphase arrest in cleaving Xenopus embryos by the protein kinase p90Rsk. Science 1999; 286: 1365-1367
15. 15 Sivaraman VS, Wang H, Nuovo GJ, Malbon CC. Hyperexpression of mitogen-activated protein kinase in human breast cancer. J Clin Invest 1997; 99: 1478-1483
16. 16 Brown JW, Puppala K, Neary JT, Fishman LM. Mitogen-activated protein kinase (MAPK) activity in varying types of human pheochromocytomas. Proc Soc Expl Biol 1998; Abstract A7: 22
17. 17 Migliaccio A, Di Domenico M, Castoria G, de Falco A, Bontempo P, Nola E, Auricchio F. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 1996; 15: 1292-1300
18. 18 Nuedling S, Kahlert S, Loebbert K, Meyer R, Vetter H, Grohe C. Differential effects of 17beta-estradiol on mitogen-activated protein kinase pathways in rat carciomyocytes. FEBS Lett 1999; 454: 271-276
19. 19 Singh M, Setalo G Jr, Guan X, Warren M, Toran-Allerand CD. Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants; convergence of estrogen and neurotrophin signaling pathways. J Neurosci 1999; 19: 1179-1188
20. 20 Zhu X, Li H, Liu JP, Funder JW. Androgen stimulates mitogen-activated protein kinase in human breast cancer cells. Mol Cell Endocrinol 1999; 152: 199-206
21. 21 Nader S, Hickey RC, Sellin R, Samaan NA. Adrenal cortical carcinoma. A study of 77 cases. Cancer 1983; 51: 707-711
22. 22 DePablos, VPL, Martinez MP, Sanchez MV, Santana AC, Martinez-Martin J, Hernandez RJ. An adrenal carcinoma producing androgens, estrogens, and cortisol. Anales de Medicina Interna 1997; 14: 190-192
23. 23 Muthusethupathi MA, Vimala A, Jayakumar M, Rajendran S. Normotensive primary aldosteronism due to adrenocortical carcinoma. Nephron 1998; 79: 247-248
24. 24Brown JW, Fishman LM. Biosynthesis and metabolism of steroid hormones by human adrenal carcinomas. Brazilian J Med & Biol Res 2000; 33: 1235-1244
25. 25 Ehrhart-Bornstein M, Hilbers U. Neuroendocrine properties of adrenocortical cells. Horm Metab Res 1998; 30: 436-439
26. 26 Reincke M. Mutations in adrenocortical tumors. Horm Metab Res 1998; 30: 447-455